Related Experiment Videos
Evidence-based complementary medicine for palliative cancer care: does it make sense?
E Ernst1, J Filshie, Janet Hardy
1Complementary Medicine, Peninsula Medical School, Universities of Exeter and Plymouth, 25 Victoria Park Road, Exeter EX2 4NT, UK. Edzard.Ernst@pms.ac.uk
Palliative Medicine
|December 26, 2003
Summary
Rigorous scientific trials are crucial for advancing complementary medicine in palliative cancer care. While patient appreciation is noted, evidence-based research ensures future patient benefit and hinders detrimental practices.
Area of Science:
- Palliative Care
- Complementary Medicine
- Evidence-Based Practice
Background:
- Complementary medicine is increasingly integrated into palliative cancer care.
- A debate exists regarding the necessity of randomized clinical trials versus patient-reported appreciation for these therapies.
Purpose of the Study:
- To explore arguments for and against rigorous scientific evaluation of complementary medicine in palliative cancer care.
- To highlight the challenges and benefits associated with different research approaches.
Main Methods:
- Discussion of logistical, ethical, and methodological challenges in palliative care research.
- Analysis of the costs associated with clinical trials for complementary therapies.
- Consideration of the value of patient appreciation versus empirical evidence.
Main Results:
- Conducting research in palliative care presents significant logistical and ethical hurdles.
- Standardizing treatments and quantifying subtle effects are methodologically difficult.
- The costs of clinical trials can be substantial.
Conclusions:
- Neither complete acceptance nor rejection of rigorous trials is fully justified.
- The absence of robust scientific evidence will impede progress in palliative cancer care.
- A balanced approach, learning from both sides, is essential for future patient well-being.